Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002729152 | SCV003563500 | uncertain significance | Inborn genetic diseases | 2021-07-20 | criteria provided, single submitter | clinical testing | The c.3026A>C (p.E1009A) alteration is located in exon 15 (coding exon 15) of the SYNGAP1 gene. This alteration results from a A to C substitution at nucleotide position 3026, causing the glutamic acid (E) at amino acid position 1009 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |